Ventricular fibrillation development following atrial fibrillation after the ingestion of sildenaphil in a patient with Wolff-Parkinson-White syndrome Article Swipe

PDF

Related Concepts

Medicine Atrial fibrillation Accessory pathway Cardiology Internal medicine Ventricular fibrillation WPW SYNDROME Fibrillation Catheter ablation Tachycardia

Sinan İnci , İbrahim İzgü , Halil Aktaş , Pınar Doğan , Ali Doğan ·

YOU? · · 2015 · Open Access · · DOI: https://doi.org/10.5582/irdr.2015.01030 · OA: W1238569378

Complications in the accessory pathway in Wolff-Parkinson-White (WPW) syndrome could cause different clinical conditions by inducing different arrhythmias. Atrial fibrillation (AF) is one of these arrhythmias and is important as it causes life-threatening arrhythmias. It is known that some drugs, underlying cardiac diseases, and the number of accessory pathways, cause a predisposition to this condition. In the current report, we presented a patient with WPW who was admitted to the emergency department with AF, wide QRS and a rapid ventricular response that progressed to ventricular fibrillation.